Donanemab and lecanemab have been shown to delay progression from mild to moderate Alzheimer's by up to six months but are not currently available on NHS.

Those people had roughly a twofold higher risk. It is important to note that this data was taken from a health registry. This ...

False diagnoses are used to mask inappropriate use of antipsychotic drugs on patients with dementia, a practice called chemical restraint, a government watchdog report said.

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

New microlearning video series to support the safer use of psychotropic medications in residential aged care; New microlearning video series t ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

A recent study shows that combining magnetic brain scans with computer models can safely measure how dementia medications affect living human brains. This approach could replace invasive tests and ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nitrogen-containing bisphosphonates (NBPs), a ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...

A BBC health expert has discussed a new study showing increased mortality risks for people with dementia taking certain antidepressants like Sertraline, Citalopram and Fluoxetine ...

Dr Oscar Duke discusses Queen's University study showing antidepressants like Sertraline and Citalopram may increase ...